Sign inGet started

Brownstein Carrie

Insider CIK 1894232 · STTK Director · ZNTL Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
STTK Shattuck Labs, Inc. A Award deriv2025-07-142025-07-1633,150— $033,150SEC↗
STTK Shattuck Labs, Inc. A Award deriv2024-06-212024-06-2127,700— $027,700SEC↗
ZNTL Zentalis Pharmaceuticals, S Sale2023-10-042023-10-068,906$19.43 $173.0K107,407SEC↗
ZNTL Zentalis Pharmaceuticals, S Sale2023-10-042023-10-061,722$19.91 $34.3K105,685SEC↗
STTK Shattuck Labs, Inc. A Award deriv2023-05-262023-05-3140,258— $040,258SEC↗
ZNTL Zentalis Pharmaceuticals, A Award deriv2023-02-012023-02-0123,687— $023,687SEC↗
ZNTL Zentalis Pharmaceuticals, A Award2023-02-012023-02-0116,313— $0116,313SEC↗
ZNTL Zentalis Pharmaceuticals, A Award deriv2022-10-032022-10-03100,000— $0100,000SEC↗
ZNTL Zentalis Pharmaceuticals, A Award deriv2022-10-032022-10-03300,000— $0300,000SEC↗
ZNTL Zentalis Pharmaceuticals, A Award2022-10-032022-10-03100,000— $0100,000SEC↗
STTK Shattuck Labs, Inc. A Award deriv2022-06-082022-06-1040,258— $040,258SEC↗
STTK Shattuck Labs, Inc. A Award deriv2021-11-122021-11-1710,467— $010,467SEC↗